|
REPS1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.36317648677687E-14 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.67088565206086E-12 |
| Normal-vs-Stage2 |
1.41599999503583E-08 |
| Normal-vs-Stage3 |
7.61670000000159E-05 |
| Normal-vs-Stage4 |
1.223540E-02 |
| Stage1-vs-Stage2 |
9.637200E-01 |
| Stage1-vs-Stage3 |
2.271800E-01 |
| Stage1-vs-Stage4 |
7.962200E-01 |
| Stage2-vs-Stage3 |
2.936800E-01 |
| Stage2-vs-Stage4 |
7.736600E-01 |
| Stage3-vs-Stage4 |
6.363000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.99360577730113E-15 |
| Normal-vs-AfricanAmerican |
3.82089999639845E-08 |
| Normal-vs-Asian |
1.579109999994E-05 |
| Caucasian-vs-AfricanAmerican |
8.693700E-02 |
| Caucasian-vs-Asian |
7.607400E-01 |
| AfricanAmerican-vs-Asian |
3.627000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62525548574877E-12 |
| Normal-vs-Female |
1.74900999999617E-05 |
| Male-vs-Female |
1.557380E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.39869999973941E-07 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
2.93210000723576E-09 |
| Normal-vs-Extreme_Obese |
1.142530E-03 |
| Normal_Weight-vs-Extreme_Weight |
7.366000E-02 |
| Normal_Weight-vs-Obese |
6.199400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.015000E-01 |
| Extreme_Weight-vs-Obese |
3.078300E-03 |
| Extreme_Weight-vs-Extreme_Obese |
7.348200E-01 |
| Obese-vs-Extreme_Obese |
2.610200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.522900E-03 |
| Normal-vs-Age(41-60Yrs) |
1.18216547662087E-12 |
| Normal-vs-Age(61-80Yrs) |
1.56541446472147E-14 |
| Normal-vs-Age(81-100Yrs) |
8.40720000000461E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.629200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.969240E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.353180E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.829600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.880600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.180600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62592161956354E-12 |
| Normal-VS-Type2 PRCC |
8.89989970609406E-10 |
| Normal-VS-KIRP CIMP |
7.455700E-02 |
| Normal-VS-Unclassified PRCC |
7.50080000333497E-08 |
| Type1 PRCC-VS-Type2 PRCC |
1.668210E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.577500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.920400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.667000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.814400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.566760E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.22044604925031E-16 |
| Normal-vs-N1 |
1.172150E-02 |
| Normal-vs-N2 |
2.06579999773027E-08 |
| N0-vs-N1 |
2.48219999999799E-05 |
| N0-vs-N2 |
1.854190E-01 |
| N1-vs-N2 |
6.257700E-03 |
|
|
